BANK OF MONTREAL /CAN/ - JUNO THERAPEUTICS INC ownership

JUNO THERAPEUTICS INC's ticker is JUNO and the CUSIP is 48205A109. A total of 166 filers reported holding JUNO THERAPEUTICS INC in Q4 2016. The put-call ratio across all filers is 1.25 and the average weighting 1.0%.

Quarter-by-quarter ownership
BANK OF MONTREAL /CAN/ ownership history of JUNO THERAPEUTICS INC
ValueSharesWeighting
Q4 2017$476,000
+9.2%
10,407
+7.0%
0.00%
Q3 2017$436,000
+57.4%
9,728
+5.2%
0.00%
Q2 2017$277,000
-39.0%
9,248
-54.8%
0.00%
Q1 2017$454,000
+57.6%
20,463
+42.3%
0.00%
Q4 2016$288,000
-32.6%
14,379
+1.0%
0.00%
Q3 2016$427,000
+42600.0%
14,238
+37368.4%
0.00%
Q2 2016$1,000
-99.9%
38
-99.8%
0.00%
Q1 2016$816,000
+1940.0%
21,400
+2277.8%
0.00%
Q4 2015$40,0009000.00%
Other shareholders
JUNO THERAPEUTICS INC shareholders Q4 2016
NameSharesValueWeighting ↓
Crestline Management, LP 25,948,799$1,055,857,000100.00%
Omega Fund Management, LLC 1,329,512$54,098,00030.46%
SOUND ENERGY PARTNERS, INC. 25,800$1,050,0002.12%
Graticule Asia Macro Advisors LLC 435,205$17,708,0002.06%
BB BIOTECH AG 1,305,000$53,100,0001.68%
Kazazian Asset Management, LLC 13,376$544,0000.69%
Rock Springs Capital Management LP 197,001$8,016,0000.65%
TURNER INVESTMENTS LLC 69,680$2,835,0000.57%
MIZUHO SECURITIES USA LLC 49,600$2,018,0000.52%
Private Capital Advisors, Inc. 27,900$1,135,0000.48%
View complete list of JUNO THERAPEUTICS INC shareholders